The results showed that the expression of MMP9 and Vimentin were indeed reduced along with the knockdown of CD44 in ccRCC cells, leading to a restraint of EMT (Fig. 7G). The gene discussed is MMP9; the disease is nonpapillary renal cell carcinoma.